In this article, we will discuss Durvalumab (Dosage-3). So, let’s get started.
ES-SCLC
- Patients with a body weight of less than 30 kg: 20 mg/kg in combination with chemotherapy* every 3 weeks (21 days) for 4 cycles, followed by 10 mg/kg every 2 weeks as a single agent